CYAN
CYANOTECH CORPCompany Information
- Company Name
- CYANOTECH CORP
- CIK
- CIK0000768408
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- CYAN: OTC
- Fiscal Year End
- March 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2833
- SIC Description
- Medicinal Chemicals & Botanical Products
- Ticker
- CYAN
SEC filing data through
Insider Sentiment
- Last purchase
- 2024-10-01
- Last sale
- —
- Shares purchased (TTM)
- 607,955
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2023-12-31
- Institutional shares owned
- 188,782
- Shares outstanding
- 6,554,000
- Ownership
- 2.88%
Earnings Market Reaction
- Filing date
- 2025-11-10
- Price on filing date
- —
- 1-month reaction
- 20.51%
- 3-month reaction
- 35.90%
Balance Sheet
Values in millions ($)| Line item | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Accounts Receivable Net Current | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 2 | 1 | 2 | ||||||
| Inventory Net | 8 | 8 | 8 | 8 | 7 | 7 | 7 | 9 | 10 | 11 | 11 | 12 | ||||||
| Prepaid Expense And Other Assets Current | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets Current | 12 | 11 | 11 | 11 | 10 | 10 | 11 | 12 | 13 | 13 | 13 | 15 | ||||||
| Property Plant And Equipment Net | 8 | 9 | 9 | 9 | 10 | 10 | 10 | 10 | 11 | 11 | 11 | 12 | ||||||
| Operating Lease Right Of Use Asset | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 5 | 5 | 5 | 3 | ||||||
| Other Assets Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets | 24 | 23 | 23 | 24 | 24 | 24 | 25 | 27 | 28 | 29 | 30 | 30 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 3 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 2 | 1 | 1 | ||||||
| Accrued Liabilities Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Contract With Customer Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Operating Lease Liability Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | ||||||
| Short Term Borrowings | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | - | - | 0 | - | ||||||
| Lines Of Credit Current | - | - | - | - | - | - | 0 | 0 | 1 | 2 | 2 | 2 | ||||||
| Long Term Debt Current | - | - | 3 | - | 6 | - | 3 | - | - | - | - | - | ||||||
| Liabilities Current | 12 | 11 | 10 | 10 | 10 | 10 | 9 | 9 | 9 | 9 | 8 | 5 | ||||||
| Long Term Debt Noncurrent | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 4 | ||||||
| Operating Lease Liability Noncurrent | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 3 | ||||||
| Liabilities | 16 | 15 | 15 | 14 | 14 | 14 | 13 | 13 | 14 | 14 | 13 | 12 | ||||||
| Other Liabilities Noncurrent | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Stockholders Equity | ||||||||||||||||||
| Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 35 | 35 | 35 | 35 | 35 | 35 | 35 | 35 | 34 | 34 | 34 | 34 | ||||||
| Retained Earnings Accumulated Deficit | -27 | -27 | -26 | -25 | -25 | -24 | -23 | -21 | -20 | -19 | -18 | -16 | ||||||
| Stockholders Equity | 8 | 8 | 9 | 10 | 10 | 11 | 12 | 14 | 14 | 15 | 16 | 18 | ||||||
| Liabilities And Stockholders Equity | 24 | 23 | 23 | 24 | 24 | 24 | 25 | 27 | 28 | 29 | 30 | 30 | ||||||
| Allowance For Doubtful Accounts Receivable Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | ||||||
| Preferred Stock Shares Authorized | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | ||||||
| Common Stock Shares Authorized | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | ||||||
| Common Stock Shares Issued | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 6 | 6 | 6 | 6 | ||||||
| Shares Outstanding | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 6 | 6 | 6 | 6 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialCYANOTECH CORP (CYAN) — SEC Financial Statements & Analysis
CYANOTECH CORP (CYAN) is a medicinal chemicals & botanical products company, incorporated in NV. CYANOTECH CORP trades on OTC as: CYAN. CYANOTECH CORP (CYAN)'s most recent SEC filing is a Form 10-Q for the period ended 2025-09-30, filed with the SEC on 2025-11-10. Based on that filing, CYANOTECH CORP carries a market cap of $2.19M, a P/E ratio of -1.23x, a P/B ratio of 0.27x, a P/S ratio of 0.09x, an enterprise value of $2.91M, and an EV/EBITDA multiple of -3.71x. On profitability, it posts a gross margin of 29.72%, an operating margin of -9.20%, a net margin of -7.36%, a Return on Equity (ROE) of -20.00%, a Return on Assets (ROA) of -7.41%, and a Return on Invested Capital (ROIC) of -16.57%. Per share, it reports EPS of $-0.24, diluted EPS of $-0.24, free cash flow per share of $-0.20, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 1.32% year-over-year, net income growth of -67.43% year-over-year, and EPS growth of -68.72% year-over-year. On the balance sheet, it maintains a current ratio of 1.00x, a quick ratio of 0.25x, working capital of $39.00K, a debt-to-equity ratio of 1.98x, a debt ratio of 0.66, an interest coverage ratio of -3.11x, free cash flow of $-1.44M (TTM), and net debt of $721.00K. Figures sourced from SEC EDGAR.
- Market Cap
- $2.19M
- P/E TTM
- -1.23x
- EPS TTM
- $-0.24
- P/B TTM
- 0.27x
- ROE TTM
- -20.00%
- ROA TTM
- -7.41%
- Debt To Equity
- 1.98x
- Free Cash Flow TTM
- $-1.44M
- Net Revenue TTM Growth 1Y
- 1.32%
Data as of 2025-09-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is CYANOTECH CORP in?
CYANOTECH CORP (CYAN) operates in the Medicinal Chemicals & Botanical Products industry.
What exchange does CYAN trade on?
CYANOTECH CORP (CYAN) trades on the OTC.
Where is CYANOTECH CORP incorporated?
CYANOTECH CORP is incorporated in NV.
When was CYANOTECH CORP (CYAN)'s most recent SEC filing?
CYANOTECH CORP (CYAN)'s most recent SEC filing is a Form 10-Q for the period ended 2025-09-30, filed with the SEC on 2025-11-10.
What is CYAN's market cap?
CYANOTECH CORP (CYAN) has a market capitalization of $2.19M as of 2025-09-30.
What is CYAN's EPS (earnings per share)?
CYANOTECH CORP (CYAN)'s trailing twelve month EPS is $-0.24 as of 2025-09-30.
What is CYAN's ROE (return on equity)?
CYANOTECH CORP (CYAN)'s trailing twelve month Return on Equity (ROE) is -20.00% as of 2025-09-30.
What is CYAN's ROA (return on assets)?
CYANOTECH CORP (CYAN)'s trailing twelve month Return on Assets (ROA) is -7.41% as of 2025-09-30.
What is CYAN's ROIC (return on invested capital)?
CYANOTECH CORP (CYAN)'s trailing twelve month Return on Invested Capital (ROIC) is -16.57% as of 2025-09-30.
What is CYAN's EV/EBITDA?
CYANOTECH CORP (CYAN)'s trailing twelve month EV/EBITDA is -3.71x as of 2025-09-30.